deltatrials

Short bowel syndrome Trials in Berlin, Germany

Conditions / Short bowel syndrome / Berlin, Germany

Research into Short bowel syndrome spans multiple therapeutic approaches and trial phases.

11 total trials for this combination

Showing top 10 of 11 trials

Trials

NCT ID Title Status Phase
NCT06904872 Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC) RECRUITING PHASE2
NCT00081458 Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome COMPLETED PHASE3
NCT04881825 Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial ACTIVE_NOT_RECRUITING PHASE3
NCT04627025 Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF COMPLETED PHASE3
NCT07197944 Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS RECRUITING PHASE3
NCT00798967 Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) Subjects COMPLETED PHASE3
NCT05018286 Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome. ACTIVE_NOT_RECRUITING PHASE3
NCT03690206 Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS) COMPLETED PHASE3
NCT00930644 Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS) COMPLETED PHASE3
NCT03905707 Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS ACTIVE_NOT_RECRUITING PHASE3

Related Pages